Access to Investigational Drugs: FDA Expanded Access Programs or “Right‐to‐Try” Legislation?

Ítems similars

• Right now, in the right way: U. S. Food and Drug Administration’s expanded access program and patient rights
  per: Holbein, M. E. Blair, et al.
  Publicat: (2018)
• Understanding FDA Regulatory Requirements for an Investigational Device Exemption (IDE) for Sponsor-Investigators
  per: Blair Holbein, M. E., et al.
  Publicat: (2012)
• Overview of FDA’s Expanded Access Program for Investigational Drugs
  per: Jarow, Jonathan P., et al.
  Publicat: (2017)
• Expanded Access Versus Right-to-Try
  per: Walker, Scot
  Publicat: (2019)
• Expanding Patient Access to Investigational Drugs: Single Patient Investigational New Drug and the “Right to Try”
  per: Van Norman, Gail A.
  Publicat: (2018)